Brainstorm Cell Therapeutics (BCLI) Research & Development (2010 - 2026)
Brainstorm Cell Therapeutics' Research & Development came in at $963,000 for Q2 2026, down 14.0% from $1.12 million a year earlier but up 26.4% from the prior quarter.
Powered by 
Analysis
Brainstorm Cell Therapeutics (BCLI) Research & Development (2010 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Brainstorm Cell Therapeutics reported Research & Development of $3.48 million, down 33.1% year-over-year; for FY2025, it was $4.18 million, down 10.2% from FY2024.
- Research & Development has declined in each of the last five years, with a five-year compound annual growth rate of -28.5% (FY2020 to FY2025).
- Going back by year, Research & Development was $4.65 million in FY2024 (-56.7%), $10.75 million in FY2023 (-23.0%), $13.96 million in FY2022 (-8.4%) and $15.24 million in FY2021 (-31.8%).
- The five-year range for quarterly Research & Development is $762,000 (Q1 2026) to $5.11 million (Q2 2022).
- Year-over-year, Research & Development has declined for four consecutive quarters, with an average decline of 16.3% over the last eight quarters.
- The fastest year-over-year change in Research & Development over five years came in Q3 2021 (growth of 93.8%), and the weakest in Q3 2024 (a decline of 68.6%).
- Business Quant data shows BCLI's Research & Development at $762,000 (Q1 2026), $852,000 (Q4 2025) and $899,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 3.82 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 3.65 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 2.34 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 9.74 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 1.87 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 1.76 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 2.81 Bn |
| 10 | Brainstorm Cell Therapeutics | 8.50 Mn | 8.43 Mn | - | 963,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 963,000.00 |
| Mar 31, 2026 | 762,000.00 |
| Dec 31, 2025 | 852,000.00 |
| Sep 30, 2025 | 899,000.00 |
| Jun 30, 2025 | 1.12 Mn |
| Mar 31, 2025 | 1.30 Mn |
| Dec 31, 2024 | 1.72 Mn |
| Sep 30, 2024 | 1.05 Mn |
| Jun 30, 2024 | 922,000.00 |
| Mar 31, 2024 | 961,000.00 |
| Dec 31, 2023 | 1.70 Mn |
| Sep 30, 2023 | 3.33 Mn |
| Jun 30, 2023 | 2.79 Mn |
| Mar 31, 2023 | 2.92 Mn |
| Dec 31, 2022 | 2.45 Mn |
| Sep 30, 2022 | 3.78 Mn |
| Jun 30, 2022 | 5.11 Mn |
| Mar 31, 2022 | 2.62 Mn |
| Dec 31, 2021 | 3.68 Mn |
| Sep 30, 2021 | 3.62 Mn |
API Access
Brainstorm Cell Therapeutics Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=BCLI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "BCLI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=BCLI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();